Background
==========

Spinal cord injury (SCI) often results in functional deficits, inflammation, and tissue degradation \[[@b1-medscimonit-23-4241]\]. It has many causes, such as traffic accidents and work-related juries. Researchers have made great efforts to develop several therapeutic strategies, including administration of growth factors \[[@b2-medscimonit-23-4241]\], tissue bridges \[[@b3-medscimonit-23-4241]\], various cell types \[[@b4-medscimonit-23-4241],[@b5-medscimonit-23-4241]\], and artificial scaffolds \[[@b1-medscimonit-23-4241],[@b6-medscimonit-23-4241]\]. However, at present, there remains a lack of effective treatments for SCI.

Acupuncture has been practiced in China for thousands of years. It has been reported to have therapeutic effects in patients suffering from SCI \[[@b7-medscimonit-23-4241],[@b8-medscimonit-23-4241]\], apoplexy \[[@b9-medscimonit-23-4241]\], and inflammatory diseases \[[@b10-medscimonit-23-4241]\]. Electro-acupuncture (EA) is a widely-used method of acupuncture today. Increasing studies have used spinal cord-transected rat models to mimic SCI, and demonstrated that EA stimulation leads to neuroprotection and neuronal function recovery in spinal cord-transected rats \[[@b11-medscimonit-23-4241]--[@b13-medscimonit-23-4241]\]. However, the underlying mechanisms have not been fully elucidated.

A promising therapeutic strategy for SCI is to promote functional recovery of neurons. cAMP and Schwann cells are able to promote axonal growth and functional recovery after SCI \[[@b14-medscimonit-23-4241]\], and neurotrophic factors (NTFs) and transplants are reported to increase regeneration and functional recovery of axons after SCI \[[@b15-medscimonit-23-4241]\]. NTFs are important factors influencing neuronal plasticity following nerve injury \[[@b16-medscimonit-23-4241]\]. A rich body of evidence demonstrates that EA therapy can change the expression of NTFs and strengthen spinal neuroplasticity following SCI \[[@b17-medscimonit-23-4241],[@b18-medscimonit-23-4241]\]. Recently, Mo et al. reported that electro-acupuncture at Governor Vessel Acupoints (Dazhui and Mingmen) increased the expression of neurotrophin-3 in rats with SCI \[[@b11-medscimonit-23-4241]\]. Liu et al. found that EA therapy downregulates platelet-derived growth factor (PDGF) \[[@b19-medscimonit-23-4241]\]. However, there are few systematic analyses of NTFs by using EA after spinal cord transection (SCT).

Therefore, the present study aimed to investigate the effect of EA on multiple NTFs and their receptors in the caudal spinal segment (CSS) to the site of transection in spinal cord-transected rats. We also investigated the possible recovery of sensory and motor functions and axonal regeneration.

Material and Methods
====================

Animals
-------

Sprague-Dawley rats (180--220 g) were provided by the Laboratory Animal Center of Sichuan University. These experiments were approved by the Animal Care and Use Committee of Sichuan University (No. 20090920002). A total of 144 rats were randomly divided into 3 groups (n=48 per group): sham-operated controls group (group I), SCT group (group II), and EA group (group III). SCT group rats received spinal cord transection surgery between T~10~ and T~11~ vertebral levels. EA group rats received SCT surgery and then EA treatment.

Surgical procedures
-------------------

Surgical SCT \[[@b11-medscimonit-23-4241]--[@b13-medscimonit-23-4241]\] was performed in SCT group and EA group rats. Briefly, after deep anaesthetizing with chloral hydrate, the rats were incised in the midline on the back and the muscles were retracted. T~11~ vertebral lamina was removed followed by incision of the dura mater. Subsequently, the spinal cord between T~10~ and T~11~ vertebral levels was transected. Finally, the wound was sutured. The sham-operated control group only received laminectomy without touching the spinal cord.

Electro-acupuncture
-------------------

The rats of the SCT group were given 1, 3, 7, 14, and 28 days (n=8 for each point of time) of EA therapy at 2 pairs of acupoints, *Zusanli*-*Xuanzhong* and *Futu*-*Sanyinjiao*. These acupoints were identified according to previous studies \[[@b19-medscimonit-23-4241],[@b20-medscimonit-23-4241]\]. These acupoints were stimulated in pairs (*Zusanli* and *Xuanzhong*, or *Futu* and *Sanyingjiao*), with each pair being stimulated on alternate days for 30 min (frequency=98 HZ). The stimulating electrodes were changed and their polarity reversed after 15 min.

Reverse transcription polymerase chain reaction (RT-PCR)
--------------------------------------------------------

To determine the expression patterns of NTFs and their receptors in each group, 8 rats of the SCT group and the EA group were kept alive for 1, 3, 7, and 14 days post-operation (dpo), separately, and used for RT-PCR analysis. Rats were sacrificed after receiving an overdose of chloral hydrate, and then the spinal cords at T10 were harvested. Total RNA was extracted from each spinal cord sample (50 mg). cDNA was generated using the cDNA Synthesis kit (Fermentas, EU). Primers used for PCR amplification of nerve growth factor (NGF), PDGF, ciliary neurotrophic factor (CNTF), insulin-like growth factor (IGF), fibroblast growth factor (FGF), tropomyosin receptor kinase (Trk)A, TrkB, TrkC, and tumor growth factor (TGF)-β1 cDNA samples are shown in [Table 1](#t1-medscimonit-23-4241){ref-type="table"}. The mRNA level of each gene is expressed by the gray-scale intensity relative to β-actin level (internal control).

*In situ* hybridization
-----------------------

For detecting the expression and location of NTFs and receptors, 8 rats were randomly chosen from each group for *in situ* hybridization (ISH) and immunohistochemistry (IHC). The spinal cords of rats were harvested, and cut into sections at 20-μm thicknesses. The sections were fixed in 4% paraformaldehyde, and acetylated with 0.25% acetic anhydride. Prior to hybridizing in hybridization solution with the probes of NTFs for 12--16 h (37°C), the sections were prehybridized in a hybridization solution without probes. Subsequently, the sections were blocked at 37°C for 1 h, immersed in sheep anti-digoxygenin-alkaline phosphatase (AP) antibody (1: 1000) at 4°C overnight, and finally visualized with blue and purple sedimentation ([Table 2](#t2-medscimonit-23-4241){ref-type="table"}).

Immunohistochemistry
--------------------

The tissue sections of spinal cords at 20 μm thicknesses were processed for immunohistochemistry as described previously \[[@b21-medscimonit-23-4241]\]. Briefly, the sections were incubated with rabbit anti-rat polyclonal antibodies at 4°C overnight ([Table 3](#t3-medscimonit-23-4241){ref-type="table"}). Negative controls were incubated in 2% goat serum instead of the primary antibody. Finally, the sections were detected by diaminobenzidine staining. Immuno-reactive staining was observed under a light microscope (Leica, Bensheim, Germany).

Biotinylated dextran amine (BDA) tracing
----------------------------------------

For evaluating BDA axonal tracing, animals were anesthetized at 4 weeks post-operation, and biotinylated dextran amine was injected as previously described \[[@b13-medscimonit-23-4241]\]. The rats were sacrificed after 3 weeks and prepared for histological analysis. The spinal cord was post-fixed in 4% paraformaldehyde for 3 days. Transverse sections (30 μm) were made on the injured site and on spinal segments rostral and caudal to the lesion. Some sections were used to detect whether the BDA-labeled regenerating axons were present. The remaining sections were used for immuno-histochemistry.

Hindlimb locomotor functions
----------------------------

Restoration of hindlimb locomotor function of the rats (n=8 for each group) was evaluated using the Basso, Beattie, Bresnahan (BBB) rat rating scale \[[@b22-medscimonit-23-4241]\]. Briefly, motor performance of each rat was evaluated at 8 to 9: 00 am in an open-field arena at 1, 2, 3, and 4 weeks after injury. All the behavior evaluations were scored by 3 investigators who were blind to the operative procedure.

Measurement of cortical somatosensory evoked potentials (CSEP)
--------------------------------------------------------------

In order to evaluate the restoration of sensory functions, CSEP at 14, 21, 28 days post-operation was recorded by using a KEYPOINT Electromyography instrument (Medtronic, Minnesota, USA). The CSEP was measured as previously described \[[@b13-medscimonit-23-4241]\]. The right common peroneal nerve was located based on surface landmarks and a stimulating electrode placed over the nerve. A recording electrode was placed over the dura overlying the somatosensory cortex through a small craniotomy (2 mm left of the midline and 2 mm anterior to the posterior fontanelle). The reference electrode was inserted on the nose, and the ground electrode was inserted on the tail. The stimulus intensity was set high enough to produce a marked muscle twitch in the hind limb (amplitude \~1.1 mA, duration of stimulation \~0.2 ms, and frequency \~3 Hz). The CSEP Tracings represented the average of 200 responses.

Statistical analysis
--------------------

Statistical analysis was performed using SPSS 10.0 software. All data are expressed as mean ±SEM (standard error of the mean). Differences of the data among the 3 groups were analyzed using one-way analysis of variance (ANOVA) followed by least significant difference (LSD)-q test. P\<0.05 was regarded as statistical significance.

Results
=======

Gene expression changes in the CSS
----------------------------------

The mRNA expression of NTFs and their receptors in the sham-operated group, the SCT group, and the EA group were detected by using RT-PCR. As shown in [Figure 1](#f1-medscimonit-23-4241){ref-type="fig"}, mRNA expression of TrkA, TrkB, TrkC, NGF, PDGF, CNTF, IGF, FGF, and TGF-β1 were detected in the spinal cord of sham-operated rats. Compared to the sham-operated group, the SCT group showed an obvious increase in the mRNA level of PDGF and TGF-β1 at 1, 3, 7, and 14 dpo, FGF-2 at 1dpo, CNTF at 1 and 3 dpo, and TrkB at 1, 7, and 14 dpo in the CSS (P\<0.05). However, no significant difference was observed in the expression of TrkA, TrkC, NGF, or IGF-I after SCT. Furthermore, in the EA group, NGF, PDGF, TGF-β1, IGF-1, TrkA and TrkC were significantly decreased (P\<0.05), while CNTF, FGF-2 and TrkB were significantly increased in the CSS to the site of transection in comparison with those in the SCT group (P\<0.05).

*In situ* hybridization
-----------------------

*In situ* hybridization revealed that these NTFs and receptors mRNA were detected in the cytoplasm of most neurons and in some glia cells in the spinal cord ([Figure 2A--2L](#f2-medscimonit-23-4241){ref-type="fig"}).

Immunohistochemical findings
----------------------------

Positive staining for NGF, PDGF, TGF-β1, CNTF, TrkA, TrkB, TrkC, IGF-1, and FGF-2 were observed in spinal neurons, including motor neurons of ventral horn and sensory neurons located in the dorsal horn. Positive staining for PDGF, CNTF, and TGF-β1were also found in some astrocytes ([Figure 3A--3L](#f3-medscimonit-23-4241){ref-type="fig"}).

Fibers of spinal lamina I, II, IV, V and motor neurons of ventral horns in the CSS were positively stained for CGRP in the sham control group and the SCT group ([Figure 4C1, C2](#f4-medscimonit-23-4241){ref-type="fig"}), respectively. The CGRP immunopositive staining was significantly strengthened in the CSS in the EA group ([Figure 4C3](#f4-medscimonit-23-4241){ref-type="fig"}).

Axonal tract tracing
--------------------

As shown in [Figure 4A1](#f4-medscimonit-23-4241){ref-type="fig"}, BDA-labeled axons were detected in the CSS of the sham-operated rats. Nevertheless, BDA-labeled axons were not observed in the same region in SCT group or EA group rats ([Figure 4A2, A3](#f4-medscimonit-23-4241){ref-type="fig"}).

5-HT immunopositive staining was found only in the sham-operated rats ([Figure 4B1--B3](#f4-medscimonit-23-4241){ref-type="fig"}). GAP-43 ([Figure 4C1--C3](#f4-medscimonit-23-4241){ref-type="fig"}) and synaptophysin ([Figure 4D1--D3](#f4-medscimonit-23-4241){ref-type="fig"}) immunopositive staining were markedly enhanced in the EA group relative to the sham-operated group and the SCT group (P\>0.05).

BBB evaluation in hindlimbs
---------------------------

[Figure 5](#f5-medscimonit-23-4241){ref-type="fig"} shows that the baseline BBB score of the sham rats was 21. The BBB score then gradually increased from 1 week to 4 weeks after injury. Moreover, the BBB score of the EA group was significantly elevated compared to that of the SCT group at 3 and 4 weeks after the operation (P\<0.05). These data suggest that EA effectively promotes locomotor functional recovery in hindlimbs.

CSEP
----

The mean latencies of P1 and N1 and the amplitude of P1-N1 of the acquired curves at different time points for all 3 groups are shown in [Table 4](#t4-medscimonit-23-4241){ref-type="table"}. However, waves of P1 and N1 could not be detected in the SCT rats. The waves of P1 and N1 at 14, 21, and 28 dpo in EA rats (bottom line) were weaker compared to the sham-operated rats ([Figure 6](#f6-medscimonit-23-4241){ref-type="fig"}).

Discussion
==========

The present study aimed to investigate the possible effects of EA stimulation on systematic regulation of multiple gene expressions in SCT rats. Changes in the expression of NTFs and tyrosine kinase receptors were observed in the CSS. Parallel to the gene changes, we found partial axonal regeneration and recovery of functions.

In the present study, CNTF, FGF-2, and TrkB were upregulated in the CSS, while others, like NGF, PDGF, TGF-β1, IGF-1 TrkA, and TrkC, were downregulated after EA treatment. These findings suggest that NTFs and their receptors play different roles in the CSS of SCT rats with EA treatment. EA may induce neural plasticity through systematic upregulation of NTFs or their receptors. BDNF, combined with its functional receptor TrkB, plays an important role in inducing neurite outgrowth of both sensory \[[@b23-medscimonit-23-4241]\] and motor neurons \[[@b24-medscimonit-23-4241]\]. In addition, FGF-2 has been shown to promote the outgrowth of neurites from ventral spinal cord neurons \[[@b25-medscimonit-23-4241]\]. CNTF is a potent factor that induces growth of axons from sensory and motor neurons of the spinal cord \[[@b26-medscimonit-23-4241]\]. These NTFs and receptors are important to the recovery of the injured spinal cord \[[@b23-medscimonit-23-4241],[@b27-medscimonit-23-4241]\]. Our data provide direct evidence to map the regulated genes by EA stimulation in injured spinal cord, and provide a basis for finding new strategies using NTF synergistic administration for treatment of SCI in future clinical trials.

Significant decreases of NGF, PDGF, TGF-β1, IGF-1, TrkA, and TrkC were detected in CSS after EA treatment. We found that downregulated NTFs may function together with upregulated NTF like FGF-2, depending on the systematic regulatory mechanism. PDGF, also served as a cerebrovascular permeant, plays a regulatory role in the release of MCP-1 (monocyte chemoattractant protein-1) in astrocytes. The increase in MCP-1 contributes to the neuroinflammation and blood-brain barrier disruption \[[@b28-medscimonit-23-4241]\]. It has been reported that PDGF induces the activation of astrocytes and the release of MCP-1, which further results in blood-brain barrier disruption \[[@b29-medscimonit-23-4241]\]. In addition, TGF-β1 has been shown to suppress anti-inflammation and proinflammatory mediators. A previous study has suggested that increased PDGF and TGF-β1 result in the proliferation of astrocytes, further leading to scar formation \[[@b30-medscimonit-23-4241]\]. Therefore, it is hypothesized that the downregulation of PDGF and TGF-β1 after EA may benefit the recovery of injured spinal cords. The effect of EA on neuroplasticity might result from the inhibition of neuroinflammation, which is associated with the systematic regulation of NTFs, according to our findings.

In this study, we also found that EA treatment increased the levels of GAP-43, synaptophysin, and immunopositive reactivity of CGRP in CSS. CGRP is a well-known marker for sensory axons transmitting pain sensation \[[@b31-medscimonit-23-4241]\]. The expression of CGRP is increased in motoneurons of the spinal cord in rats after peripheral axotomy \[[@b32-medscimonit-23-4241]\]. CGRP, which is closely associated with nociceptive neurons, is co-localized with GAP-43 in growing neurites \[[@b33-medscimonit-23-4241]\]. The expressions of CGRP and GAP-43 play key roles in regenerative neurite growth after spinal lesions. Increases in the number of CGRP-positive axons, GAP-43, and synaptophysin immunopositive reactivity (representing the regrowth of cone and synaptic formation) in the CSS suggests that nerve regeneration, cone regrowth, and synaptic formation are promoted in the CSS by EA treatment, which might be used to reconstruct local circuitry for further functional recovery.

Recovery of motor function was also found in the EA rats. The BBB scores in the EA rats were higher than in the SCT rats at 14, 21, and 28 dpo. These observations suggest that EA improves hindlimb locomotor function after SCT injury. In addition, significantly reduced N1 and P1 latencies were found in the EA rats at 2, 3, and 4 weeks post-operation compared to those in SCT rats, indicating that partial recovery of sensory functions was found after EA. The amplitude of P1-N1 was detected again by CSEP recordings after EA treatment, even though they were still lower than normal levels. Of these, N1 and P1 recovered to near normal levels, whereas P1 was double that of the normal values at 28 dpo. Hence, the results indicate that significant improvement in sensory function occurred in the EA rats. As we did not find regenerating corticospinal axons in CSS, it is possible that there are some subcortical contributions to the functional recovery, by rearrangement of local spinal circuits and systematic modulation of NTFs in the EA rats.

Conclusions
===========

EA stimulation promotes neuroplasticity and functional recovery of injured spinal cords by differentially regulating the expression of NTFs and receptors in the CSS. NTFs play essential roles in neuroplasticity and functional recovery of hindlimbs in spinal cord-transected rats induced by EA treatment. EA may be a potential therapeutic strategy for spinal cord injury. Clinical trials evaluating EA are warranted.
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![Gene expression of NTFs and receptors in the CSS. (**A**) mRNA level of NTFs and receptors. (**B**) Quantitative analysis. M -- marker; Sh -- sham-operated rats; S -- SCT rats. E -- EA rats. S1, S3, S7 and S14 -- 1 dpo, 3 dpo, 7 dpo, and 14 dpo of SCT rats. \* P\<0.05 among different groups.](medscimonit-23-4241-g001){#f1-medscimonit-23-4241}

![Location of mRNA for NTFs and receptors in *in situ* hybridization. (**A**) Begative control (200×, scale bar=200 μm). (**B**) NGF. (**C**) BDNF. (**D**) NT-3. (**E**) PDGF. (**F**) TGF-β1. (**G**) CNTF. (**H**) IGF-1. (**I**) FGF-2. (**J**) TrkA. (**K**) TrkB. (**L**) TrkC.](medscimonit-23-4241-g002){#f2-medscimonit-23-4241}

![Positive immunostaining for NTFs and receptors in spinal motor neurons. (**A**) Negative control (200×, scale bar=200 μm). (**B**) NGF. (**C**) BDNF. (**D**) NT-3. (**E**) PDGF. (**F**) TGF-β1. (**G**) CNTF. (**H**) IGF-1. (**I**) FGF-2. (**J**) TrkA. (**K**) TrkB. (**L**) TrkC.](medscimonit-23-4241-g003){#f3-medscimonit-23-4241}

![Axonal regeneration and growth. (**A1--A3**) Staining of BDA-labeled axons in sham-operated rats, SCT rats, and EA rats, respectively. (**B1--B3**) Staining of 5-HT. (**C1--C3**) CGRP immuno-reactive staining. (**D1--D3**) GAP-43 immuno-reactive staining. (**E1--E3**) Synaptophysin immuno-reactive staining. (**F**) Quantitative analyses of GAP-43, synaptophysin and CGRP.\* P\<0.05 compared to sham group rats; ^\#^ P\<0.05 compared to SCT group rats. A, Scale bar=100 μm.](medscimonit-23-4241-g004){#f4-medscimonit-23-4241}

![BBB score. The BBB score of the EA rats was significantly increased compared to that of the SCT rats at 3 and 4 weeks after the operation.](medscimonit-23-4241-g005){#f5-medscimonit-23-4241}

![Detection of sensory function. The normal latencies of P1 and N1 were recorded in sham group rats, but were not observed in SCT group rats.](medscimonit-23-4241-g006){#f6-medscimonit-23-4241}

###### 

Primers for RT-PCR.

  --------------------------------------------------------------------------------------------------
  Gene      primers                                   Production (bp)   Annealing temperature (°C)
  --------- ----------------------------------------- ----------------- ----------------------------
  β-actin   Sense: 5′GTAAAGACCTCTATGCCAACA 3′\        227               52.5
            Antisense: 5′GGACTCATCGTACTCCTGCT 3′                        

  NGF       Sense: 5′AAGCCCACTGGACTAAACT 3′\          370               51
            Antisense: 5′ ACCTCCTTGCCCTTGATG 3′                         

  BDNF      Sense: 5′ TCCCTGGCTGACACTTTT 3′\          466               50
            Antisense: 5′ATTGGGTAGTTCGGCATT 3′                          

  NT-3      Sense: 5′CGTCCCTGGAAATAGTCATACGG 3′\      857               54
            Antisense: 5′GACAGATGCCAATTCATGTTCTT 3′                     

  PDGF      Sense: 5′CTGCTGCTACCTGCGTCTGG 3′\         391               55
            Antisense: 5′GCACTGCACATTGCGGTTATT 3′                       

  TGF-β1    Sense: 5′GTGAGCACTGAAGCGAAAGC3′\          332               54
            Antisense: 5′TAATGGTGGACCGCAACAAC 3′                        

  CNTF      Sense: 5′CTTTCGCAGAGCAAACACCT 3′\         422               52
            Antisense: 5′CATCCCATCAGCCTCATTTT 3′                        

  IGF-1     Sense: 5′GGCACTCTGCTTGCTCACCTT 3′\        130               57
            Antisense: 5′GCCTGTGGGCTTGTTGAAGTAAAA3′                     

  FGF-2     Sense: 5′TCCCAAGCGGCTCTACT 3′\            301               51
            Antisense: 5′ACTCCAGGCGTTCAAAGA 3′                          

  TrkA      Sense: 5′GCTGGGAGCAGGAGGATTT 3′\          417               54
            Antisense: 5′GATGCTGTTCCACGGCTTT 3′                         

  TrkB      Sense: 5′GGTTCTACAACGGAGCCATAC 3′\        248               56
            Antisense: 5′GTCTTCATAGAGGACTTCAGGGT 3′                     

  TrkC      Sense: 5′AAGCCCACCCACTACAACAAT 3′\        252               54
            Antisense: 5′ AAAGAGGACCACCAGAAGGAC 3′                      
  --------------------------------------------------------------------------------------------------

NGF -- nerve growth factor; PDGF -- platelet derived growth factor; CNTF -- ciliary neurotrophic factor; TGF-β1 -- tumor growth factor-β1; IGF -- insulin-like growth factor; FGF -- fibroblast growth factor; TrkA -- tropomyosin receptor kinase A; TrkB -- tropomyosin receptor kinase B; TrkC -- tropomyosin receptor kinase C.

###### 

Probes of NTFs and receptors for *in situ* hybridization.

  NTFs     Probes                                  Length (bp)
  -------- --------------------------------------- -------------
  NGF      5′ GCTGTGATCAGAGTGTAGAACAACATGGAC 3′    30
  BDNF     5′CCCAATGAAGAAAACAATAAGGACGCA3′         27
  NT-3     5′ATTACCAGAGCACCCTGCCCAAAGC3′           25
  PDGF     5′ CCACACCAGGAAGTTGGCATTG 3′            22
  TGF-β1   5′ TAGATTGCGTTGTTGCGGTCCACCATTAGC 3′    30
  CNTF     5′ TCTCTTGGAGTCGCTCTGCCTCAGTCATCT 3′    30
  IGF-1    5′AACGATCAGAGTAGTGGTATTTCACC3′          26
  FGF-2    5′CGGGAAGGCGCCGCTGCCGCC 3′              30
  TrkA     5′CCTCCCACACGGTAATAGAT3′                20
  TrkB     5′CTTGGCTATTAGTGAGTCCCCATTGTTCA3′       29
  TrkC     5′ CCTTGAGATGTCCGTGATGTTGATACTGGCGT3′   32

NGF -- nerve growth factor; PDGF -- platelet derived growth factor; CNTF -- ciliary neurotrophic factor; TGF-β1 -- tumor growth factor-β1; IGF -- insulin-like growth factor; FGF -- fibroblast growth factor; TrkA -- tropomyosin receptor kinase A; TrkB -- tropomyosin receptor kinase B; TrkC -- tropomyosin receptor kinase C.

###### 

Polyclonal antibodies of NTFs for immunohistochemistry.

  Primary antibody   Dilution    Source   Company
  ------------------ ----------- -------- ----------
  NGF                1: 1,00     Rabbit   Chemicom
  BDNF               1: 500      Rabbit   Santa
  NT-3               1: 1,000    Rabbit   Chemicom
  PDGF               1: 1,000    Rabbit   Chemicom
  TGF-β1             1: 20,000   Rabbit   Chemicom
  CNTF               1: 2000     Rabbit   Santa
  IGF-1              1: 200      Rabbit   Chemicom
  FGF-2              1: 100      Rabbit   Santa
  TrkA               1: 1000     Rabbit   Santa
  TrkB               1: 500      Rabbit   Santa
  TrkC               1: 800      Rabbit   Chemicom
  GAP-43             1: 10,000   Rabbit   Santa
  Synaptophysin      1: 500      Rabbit   Chemicom
  5-HT               1: 1000     Rabbit   RD
  CGRP               1: 500      Rabbit   Chemicom

NGF -- nerve growth factor; PDGF -- platelet derived growth factor; CNTF -- ciliary neurotrophic factor; TGF-β1 -- tumor growth factor-β1; IGF -- insulin-like growth factor; FGF -- fbroblast growth factor; TrkA -- tropomyosin receptor kinase A; TrkB -- tropomyosin receptor kinase B; TrkC -- tropomyosin receptor kinase C; GAP-growth associated protein; 5-HT -- 5-hydroxytryptamine; CGRP -- calcitonin gene-related peptide.

###### 

The records of cortical somatosensory evoked potential test (M±SEM).

  Time point       P1 latency (ms)                                                   N1 latency (ms)                                                   P1--N1 amplitude (μv)
  ---------------- ----------------------------------------------------------------- ----------------------------------------------------------------- -----------------------
  Sham operation   11.10±3.26                                                        22.34±4.03                                                        8.37±4.40
  SCT 14dpo        ---                                                               ---                                                               \-\--
   21dpo           ---                                                               ---                                                               \-\--
   28dpo           ---                                                               ---                                                               \-\--
  EA 14dpo         54.40±14.10[\#](#tfn5-medscimonit-23-4241){ref-type="table-fn"}   59.30a±9.89[\#](#tfn5-medscimonit-23-4241){ref-type="table-fn"}   5.37±0.58
   21dpo           25.5±10.06[\*](#tfn6-medscimonit-23-4241){ref-type="table-fn"}    28.00±7.06[\*](#tfn6-medscimonit-23-4241){ref-type="table-fn"}    5.37±0.58
   28dpo           22.17±5.37[\*](#tfn6-medscimonit-23-4241){ref-type="table-fn"}    26.33±4.41[\*](#tfn6-medscimonit-23-4241){ref-type="table-fn"}    6.06±0.32

Numbers refer to mean (M) ± standard error of mean (SEM).'---' -- latencies of P1 and N1 infinitely lengthened; '\-\--' -- no P1 and N1 amplitude;

*P*\<0.05 compare to sham operation group;

*P*\<0.05 compared to EA 14dpo.

EA -- acupuncture. dpo -- days post operation.
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